272 related articles for article (PubMed ID: 25874546)
21. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Thwaites GE; Scarborough M; Szubert A; Nsutebu E; Tilley R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS;
Lancet; 2018 Feb; 391(10121):668-678. PubMed ID: 29249276
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
[TBL] [Abstract][Full Text] [Related]
24. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
25. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
27. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Forsblom E; Tervahartiala T; Ruotsalainen E; Järvinen A; Sorsa T
PLoS One; 2021; 16(5):e0252046. PubMed ID: 34043679
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.
Yzerman EP; Boelens HA; Vogel M; Verbrugh HA
J Antimicrob Chemother; 1998 Aug; 42(2):233-9. PubMed ID: 9738842
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
31. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia.
Forsblom E; Ruotsalainen E; Ollgren J; Järvinen A
Clin Infect Dis; 2013 Feb; 56(4):527-35. PubMed ID: 23087397
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.
Hope R; Blackburn RM; Verlander NQ; Johnson AP; Kearns A; Hill R; Hopkins S; Sheridan E; Livermore DM; ;
J Antimicrob Chemother; 2013 Nov; 68(11):2641-7. PubMed ID: 23794604
[TBL] [Abstract][Full Text] [Related]
34. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
[TBL] [Abstract][Full Text] [Related]
35. The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.
Siegman-Igra Y; Reich P; Orni-Wasserlauf R; Schwartz D; Giladi M
Scand J Infect Dis; 2005; 37(8):572-578. PubMed ID: 16138425
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
[TBL] [Abstract][Full Text] [Related]
37. Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia.
Hsu MS; Huang YT; Hsu HS; Liao CH
Clin Microbiol Infect; 2014 Sep; 20(9):892-8. PubMed ID: 24612429
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Järvinen A
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1405-1413. PubMed ID: 28265815
[TBL] [Abstract][Full Text] [Related]
40. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]